![Sef P. Kurstjens](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Sef P. Kurstjens
Directeur/Membre du Conseil chez
UROVANT SCIENCES LTD.
Profil
Sef P.
Kurstjens is currently Director at Roivant Sciences, Inc., Independent Director at Urovant Sciences Ltd. since 2018, Chief Medical Officer & Executive Vice President at Urovant Sciences, Inc. since 2022, and Partner at Cambridge Innovation Capital Ltd. Former roles include President & Chief Executive Officer at Agensys, Inc. from 2010 to 2013, Director at California Healthcare Institute, Vice President-Worldwide Therapeutic at Pfizer Inc. from 1993 to 2005, Chief Medical Officer at Astellas Pharma, Inc. from 2013 to 2018, Chief Medical Officer, SVP & Head-Global Drug at Allergan UC from 2007 to 2010, and Chief Medical Officer at Astellas Pharma Global Development, Inc. from 2013 to 2018.
Education includes an undergraduate degree from the University of the Witwatersrand, conferred in 1990.
Postes actifs de Sef P. Kurstjens
| Sociétés | Poste | Début |
|---|---|---|
| UROVANT SCIENCES LTD. | Directeur/Membre du Conseil | 01/07/2018 |
Urovant Sciences, Inc.
 Urovant Sciences, Inc. Pharmaceuticals: MajorHealth Technology Operates as a clinical-stage biopharmaceutical company which develops and commercializes therapies for urologic conditions | Directeur Technique/Scientifique/R&D | 04/04/2022 |
Roivant Sciences, Inc.
 Roivant Sciences, Inc. Pharmaceuticals: MajorHealth Technology Develops and markets drugs | Directeur/Membre du Conseil | - |
Cambridge Innovation Capital Ltd
 Cambridge Innovation Capital Ltd Investment ManagersFinance Cambridge Innovation Capital seeks investment opportunities in companies located in the United Kingdom. The firm focuses on technology and life science companies. It participates in seed, early and late stage capital transactions. The firm makes co-investments. | Analyste en capital-investissement | - |
Anciens postes connus de Sef P. Kurstjens
| Sociétés | Poste | Fin |
|---|---|---|
| ASTELLAS PHARMA INC. | President | 01/04/2018 |
Astellas Pharma Global Development, Inc.
 Astellas Pharma Global Development, Inc. Pharmaceuticals: MajorHealth Technology Develops pharmaceutical products | Directeur Technique/Scientifique/R&D | 01/04/2018 |
Agensys, Inc.
 Agensys, Inc. Miscellaneous Commercial ServicesCommercial Services Develops medicines for cancers | Directeur Général | 01/01/2013 |
| ALLERGAN PLC | Directeur Technique/Scientifique/R&D | 01/01/2010 |
| PFIZER INC. | Corporate Officer/Principal | 01/01/2005 |
Formation de Sef P. Kurstjens
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
95
Relations au 1er degré
11
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 11 |
|---|---|
Pfizer Inc.
 Pfizer Inc. Pharmaceuticals: MajorHealth Technology Engages in discovery, development, manufacturing, marketing, sale and distribution of biopharmaceutical products & ingredients | Health Technology |
Agensys, Inc.
Agensys, Inc. Miscellaneous Commercial ServicesCommercial Services Develops medicines for cancers | Commercial Services |
Astellas Pharma, Inc.
 Astellas Pharma, Inc. Pharmaceuticals: MajorHealth Technology Manufactures and markets pharmaceuticals and related medical products | Health Technology |
University of the Witwatersrand
 University of the Witwatersrand Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
California Healthcare Institute
 California Healthcare Institute BiotechnologyHealth Technology Provides biomedical community services | Health Technology |
Allergan Ltd. (Ireland)
 Allergan Ltd. (Ireland) Pharmaceuticals: MajorHealth Technology Develops, manufactures and commercializes pharmaceuticals, devices, biological, surgical & regenerative medicine products | Health Technology |
Astellas Pharma Global Development, Inc.
Astellas Pharma Global Development, Inc. Pharmaceuticals: MajorHealth Technology Develops pharmaceutical products | Health Technology |
Cambridge Innovation Capital Ltd
Cambridge Innovation Capital Ltd Investment ManagersFinance Cambridge Innovation Capital seeks investment opportunities in companies located in the United Kingdom. The firm focuses on technology and life science companies. It participates in seed, early and late stage capital transactions. The firm makes co-investments. | Finance |
Roivant Sciences, Inc.
Roivant Sciences, Inc. Pharmaceuticals: MajorHealth Technology Develops and markets drugs | Health Technology |
Urovant Sciences, Inc.
Urovant Sciences, Inc. Pharmaceuticals: MajorHealth Technology Operates as a clinical-stage biopharmaceutical company which develops and commercializes therapies for urologic conditions | Health Technology |
Urovant Sciences Ltd.
 Urovant Sciences Ltd. Pharmaceuticals: MajorHealth Technology Operates as a biopharmaceutical company that develops and commercializes therapies for urologic conditions | Health Technology |
